TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$52.42
+6.09%Forward multiples
Based on analyst estimates
- P/E forward
- 18.39x
- P/E 2026E
- —
- P/E 2027E
- 17.08x
- P/E 2028E
- 11.16x
- P/S forward
- 4.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 222.81x
- Price / sales
- 7.73x
- Price / cash flow
- 28.50x
Enterprise value
- Enterprise value
- $5.2B
- EV / sales
- 7.95x
- EV / EBITDA
- -52.78x
- EV / EBIT
- -38.78x
- Market cap
- $5.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026